AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
Saved in:
| Title: | AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma. |
|---|---|
| Authors: | Chen G; Department of Biopharmaceuticals, School of Pharmacy, Air Force Medical University, Xi'an, China., Song H; Department of Interventional Therapy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China., Yang Z; Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China., Du T; People's Liberation Army (PLA) of Institute of Orthopedics Xijing Hospital, Air Force Medical University, Xi'an, China., Zheng Y; Department of Urology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.; Medical Innovation Center, Fourth Military Medical Univeristy, Xi'an, China., Lu Z; Department of Biopharmaceuticals, School of Pharmacy, Air Force Medical University, Xi'an, China., Zhang K; Department of Catheterization Room, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China., Wei D; Department of Urology, Xijing Hospital, Air Force Military Medical University, Xi'an, China. |
| Source: | Frontiers in oncology [Front Oncol] 2022 May 10; Vol. 12, pp. 890193. Date of Electronic Publication: 2022 May 10 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.890193 |
